SRCIN1 and metastatic neoplasm: In colorectal cancer (CRC)–a very aggressive metastatic tumor with active angiogenesis–miR-181a induced tube-formation in ECs and promoted angiogenesis in vivo by directly inhibiting SRC kinase signaling inhibitor 1 (SRCIN1, also known as p140Cap) [92].